PC
TRIB

Pier Capital’s Trinity Biotech TRIB Stock Holding History

Pier Capital’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-49,887
Closed -$4.56M – 139
2014
Q3 		$4.56M Sell
49,887
-496
-1% -$53.7K 0.73% 84
2014
Q2 		$5.8M Sell
50,383
-4,801
-9% -$569K 0.82% 75
2014
Q1 		$6.69M Sell
55,184
-799
-1% -$105K 0.86% 72
2013
Q4 		$7.04M Buy
+55,983
New +$6.72M 0.94% 63

Other funds holding TRIB

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Pier Capital's TRIB Position: Q4 2014 in Review

Pier Capital sold out of Trinity Biotech (TRIB) in Q4 2014, closing a stake of 49,887 shares — an estimated $4.56M sold.

Pier Capital first reported a position in TRIB in Q4 2013 and held it in 4 quarters. The position peaked at $7.04M in Q4 2013. 92 funds tracked by Wall St. Rank hold TRIB as of Q4 2014.

  • Pier Capital reported no remaining Trinity Biotech position as of Q4 2014 after selling out during the quarter.
  • Pier Capital sold 49,887 Trinity Biotech shares in Q4 2014, an estimated $4.56M.
  • Pier Capital first reported a position in Trinity Biotech in Q4 2013 and held it in 4 quarters.
  • Pier Capital's Trinity Biotech position peaked at $7.04M in Q4 2013.
  • 92 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2014.

Based on Pier Capital's 13F filing for Q4 2014, filed 10 Feb 2015.